292. CHEMOTHERAPY AND CHEMORADIOTHERAPY FOR ADENOCARCINOMA OF THE OESOPHAGUS AND JUNCTION WITH OLIGOMETASTASES: RESULTS OF THE TNT-OES-1 TRIAL
Charlène Van Der Zijden(Erasmus MC Cancer Institute), Sjoerd M. Lagarde(University of Amsterdam), Bianca Mostert(Erasmus MC), Manon C.W. Spaander(Erasmus University Rotterdam), Bas P. L. Wijnhoven(Erasmus MC Cancer Institute), Leni van Doorn(Erasmus MC), Ben M. Eyck(Erasmus MC Cancer Institute), Marjolein Y.V. Homs(Erasmus MC Cancer Institute), Joost J. Nuyttens(Erasmus MC Cancer Institute), Ate van der Gaast(Erasmus MC), Lindsey Oudijk(Erasmus MC), Tamara J. Huizer(Erasmus MC Cancer Institute), Jan van Lanschot(Erasmus MC Cancer Institute)
Cited by 0
Related Papers
Preoperative Chemoradiotherapy Versus Immediate Surgery for Resectable and Borderline Resectable Pancreatic Cancer: Results of the Dutch Randomized Phase III PREOPANC Trial
|Journal of Clinical Oncology|2020|1.1k
Ten-Year Outcome of Neoadjuvant Chemoradiotherapy Plus Surgery for Esophageal Cancer: The Randomized Controlled CROSS Trial
|Journal of Clinical Oncology|2021|788
Extended Transthoracic Resection Compared With Limited Transhiatal Resection for Adenocarcinoma of the Mid/Distal Esophagus
|Annals of Surgery|2007|709
Paediatric Gastrointestinal Endoscopy
|Journal of Pediatric Gastroenterology and Nutrition|2016|274